PDE9-IN-(S)-C33

CAS No. 2066488-39-7

PDE9-IN-(S)-C33 ( PDE9IN(S)C33; PDE9 IN (S) C33; (S)-C33 )

Catalog No. M27911 CAS No. 2066488-39-7

PDE9-IN-(S)-C33 is a potent and selective inhibitor of PDE9 (IC50 = 11 nM). PDE9-IN-(S)-C33 can be used for central nervous system diseases and diabetes research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 101 Get Quote
10MG 143 Get Quote
25MG 233 Get Quote
50MG 345 Get Quote
100MG 514 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PDE9-IN-(S)-C33
  • Note
    Research use only, not for human use.
  • Brief Description
    PDE9-IN-(S)-C33 is a potent and selective inhibitor of PDE9 (IC50 = 11 nM). PDE9-IN-(S)-C33 can be used for central nervous system diseases and diabetes research.
  • Description
    PDE9-IN-(S)-C33 is a potent and selective inhibitor of PDE9 (IC50 = 11 nM). PDE9-IN-(S)-C33 can be used for central nervous system diseases and diabetes research.
  • Synonyms
    PDE9IN(S)C33; PDE9 IN (S) C33; (S)-C33
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    Adrenocorticotropic hormone (ACTH)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2066488-39-7
  • Formula Weight
    357.8
  • Molecular Formula
    C18H20ClN5O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@H](Nc1nc2n(ncc2c(=O)[nH]1)C1CCCC1)c1ccc(Cl)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kita T, et al. Analgesic and other pharmacologic actions of saiko-saponin in repeated cold stressed (SART stressed) animals. J Pharmacobiodyn. 1980 Jun;3(6):269-80.
molnova catalog
related products
  • Triflusal

    Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981.

  • Tofimilast

    Tofimilast (CP-325366) is a potent, selective PDE4 inhibitor with IC50 of 23, 13 and 13 nM for PDE4A, PDE4B, and PDE4D, respectively.

  • Oglemilast

    Oglemilast (GRC-3886) is a potent and selective PDE4 inhibitor with IC50 of 2.5 and 1.7 nM for PDE4B and PDE4D, respectively.